{"id":8343,"date":"2025-11-13T23:02:20","date_gmt":"2025-11-13T23:02:20","guid":{"rendered":"https:\/\/mailitics.com\/index.php\/2025\/11\/13\/merck-cholesterol-pcsk9-pazdur-fda-readout-loud\/"},"modified":"2025-11-13T23:02:20","modified_gmt":"2025-11-13T23:02:20","slug":"merck-cholesterol-pcsk9-pazdur-fda-readout-loud","status":"publish","type":"post","link":"https:\/\/mailitics.com\/index.php\/2025\/11\/13\/merck-cholesterol-pcsk9-pazdur-fda-readout-loud\/","title":{"rendered":"Merck\u2019s heart disease win and the FDA\u2019s new drug regulator"},"content":{"rendered":"<p>    Merck\u2019s heart disease win and the FDA\u2019s new drug regulator<br \/>\n \t<BR><br \/>\n<BR><\/BR><br \/>\n    <!-- no image --><br \/>\n \t<BR><br \/>\n<BR><\/BR><\/p>\n<div>\n<p>What does Rick Pazdur\u2019s new role mean for the Food and Drug Administration? Has Merck solved the PCSK9 access issue? And how much credit can the president take for lowering GLP-1 drug prices?<\/p>\n<p>Dean Li, the head of R&amp;D at Merck, joins us to discuss the long-awaited trial results for the company\u2019s oral medicine targeting PCSK9 to lower cholesterol. These types of treatments have proven effective at addressing heart disease, but making them into more accessible pills has proven tricky. <\/p>\n<p><a href=\"https:\/\/www.statnews.com\/2025\/11\/13\/merck-cholesterol-pcsk9-pazdur-fda-readout-loud\/?utm_campaign=rss\">Read the rest\u2026<\/a><\/p>\n<\/div>\n<p> \t<BR><br \/>\n <BR><\/BR><br \/>\n    Allison DeAngelis, Adam Feuerstein, and Elaine Chen<br \/>\n \t<BR><br \/>\n<BR><\/BR><br \/>\n<a href=\"https:\/\/www.statnews.com\/2025\/11\/13\/merck-cholesterol-pcsk9-pazdur-fda-readout-loud\/?utm_campaign=rss\">Go to statnews<\/a><br \/>\n \t<BR><br \/>\n <BR><\/BR><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Merck\u2019s heart disease win and the FDA\u2019s new drug regulator What does Rick Pazdur\u2019s new role mean for the Food and Drug Administration? Has Merck solved the PCSK9 access issue? And how much credit can the president take for lowering GLP-1 drug prices? Dean Li, the head of R&amp;D at Merck, joins us to discuss [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2154,2486,2177,2895,2282,2612,2265],"tags":[2150],"class_list":["post-8343","post","type-post","status-publish","format-standard","hentry","category-biotechnology","category-cardiovascular-disease","category-donald-trump","category-merck","category-obesity","category-pfizer","category-the-readout-loud","tag-statnews"],"_links":{"self":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts\/8343"}],"collection":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/comments?post=8343"}],"version-history":[{"count":0,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts\/8343\/revisions"}],"wp:attachment":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/media?parent=8343"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/categories?post=8343"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/tags?post=8343"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}